Ariel Investments LLC Has $195.20 Million Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Ariel Investments LLC increased its position in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 10.7% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 2,835,203 shares of the company's stock after purchasing an additional 274,212 shares during the period. Prestige Consumer Healthcare comprises about 2.1% of Ariel Investments LLC's investment portfolio, making the stock its 16th biggest holding. Ariel Investments LLC owned 5.72% of Prestige Consumer Healthcare worth $195,204,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. The Manufacturers Life Insurance Company boosted its holdings in shares of Prestige Consumer Healthcare by 5.3% during the fourth quarter. The Manufacturers Life Insurance Company now owns 605,376 shares of the company's stock worth $37,061,000 after purchasing an additional 30,288 shares during the period. State Board of Administration of Florida Retirement System grew its holdings in shares of Prestige Consumer Healthcare by 77.4% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 25,221 shares of the company's stock valued at $1,830,000 after acquiring an additional 11,000 shares in the last quarter. Congress Asset Management Co. MA increased its stake in shares of Prestige Consumer Healthcare by 596.2% in the fourth quarter. Congress Asset Management Co. MA now owns 679,256 shares of the company's stock worth $41,584,000 after acquiring an additional 581,685 shares during the last quarter. Norges Bank purchased a new stake in shares of Prestige Consumer Healthcare during the fourth quarter worth $27,739,000. Finally, BNP Paribas Financial Markets raised its holdings in shares of Prestige Consumer Healthcare by 143.4% during the first quarter. BNP Paribas Financial Markets now owns 51,246 shares of the company's stock worth $3,718,000 after acquiring an additional 30,191 shares in the last quarter. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Stock Performance

NYSE:PBH traded up $0.57 during midday trading on Thursday, reaching $71.35. The stock had a trading volume of 198,805 shares, compared to its average volume of 247,953. The stock has a market capitalization of $3.54 billion, a P/E ratio of 17.11, a PEG ratio of 2.04 and a beta of 0.48. Prestige Consumer Healthcare Inc. has a 1-year low of $56.34 and a 1-year high of $75.80. The company has a debt-to-equity ratio of 0.65, a current ratio of 3.23 and a quick ratio of 1.90. The firm's fifty day simple moving average is $71.22 and its 200-day simple moving average is $69.64.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.90 EPS for the quarter, topping analysts' consensus estimates of $0.86 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The business had revenue of $267.10 million for the quarter, compared to analyst estimates of $260.54 million. During the same period in the previous year, the company posted $1.06 earnings per share. The firm's revenue for the quarter was down 4.4% on a year-over-year basis. On average, equities research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.42 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have commented on PBH. DA Davidson boosted their target price on Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a "buy" rating in a research note on Wednesday, August 28th. Jefferies Financial Group reissued a "hold" rating and issued a $76.00 price target (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $94.20.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.